
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across ca... Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.025 | -1.58227848101 | 1.58 | 1.79 | 1.5 | 39537 | 1.6677495 | CS |
4 | -0.115 | -6.88622754491 | 1.67 | 2.4 | 1.303 | 74871 | 1.77049136 | CS |
12 | -0.745 | -32.3913043478 | 2.3 | 2.89 | 1.0007 | 158421 | 1.77502522 | CS |
26 | -1.385 | -47.1088435374 | 2.94 | 5.22 | 1.0007 | 642510 | 2.86213496 | CS |
52 | -2.135 | -57.8590785908 | 3.69 | 5.22 | 1.0007 | 327078 | 2.86787874 | CS |
156 | -102.645 | -98.5076775432 | 104.2 | 131.857 | 1.0007 | 647348 | 11.28154335 | CS |
260 | -105.636 | -98.5493185062 | 107.191 | 134 | 1.0007 | 554870 | 15.44721126 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales